Laura Reyes-Silva

Churchill Lane
Oxford, ENG OX37LE, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis.

An adenoviral-vectored vaccine protects mice against aerosol challenge with Yersinia pestis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: June 25, 2025

An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.

An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: June 25, 2025

A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.

A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.

Journal: Science translational medicine

Published: May 07, 2025

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.

An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.

Journal: Science translational medicine

Published: June 21, 2023

Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.

Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines.

Journal: Vaccine

Published: February 06, 2023

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults.

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults.

Journal: Clinical and experimental immunology

Published: May 03, 2022

Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity.

Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity.

Journal: Frontiers in immunology

Published: March 21, 2022

Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.

Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation.

Journal: Vaccine

Published: March 10, 2022

Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus.

Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus.

Journal: Cell & bioscience

Published: December 14, 2021

Divergent trajectories of antiviral memory after SARS-CoV-2 infection.

Divergent trajectories of antiviral memory after SARS-CoV-2 infection.

Journal: Nature communications

Published: June 15, 2021

Adenovirus vectors activate Vδ2+ γδT cells in a type I interferon-, TNF-, and IL-18-dependent manner.

Adenovirus vectors activate Vδ2+ γδT cells in a type I interferon-, TNF-, and IL-18-dependent manner.

Journal: European journal of immunology

Published: May 14, 2021

MAIT cell activation augments adenovirus vector vaccine immunogenicity.

MAIT cell activation augments adenovirus vector vaccine immunogenicity.

Journal: Science (New York, N.Y.)

Published: May 01, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026